Fusion of Normoxic- and Hypoxic-Preconditioned Myoblasts Leads to Increased Hypertrophy.
C2C12
fusion
hypoxia
myoblasts
myogenic differentiation
myotube
oxygen
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
21 03 2022
21 03 2022
Historique:
received:
23
02
2022
revised:
14
03
2022
accepted:
19
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
13
4
2022
Statut:
epublish
Résumé
Injuries, high altitude, and endurance exercise lead to hypoxic conditions in skeletal muscle and sometimes to hypoxia-induced local tissue damage. Thus, regenerative myoblasts/satellite cells are exposed to different levels and durations of partial oxygen pressure depending on the spatial distance from the blood vessels. To date, it is unclear how hypoxia affects myoblasts proliferation, differentiation, and particularly fusion with normoxic myoblasts. To study this, we investigated how 21% and 2% oxygen affects C2C12 myoblast morphology, proliferation, and myogenic differentiation and evaluated the fusion of normoxic- or hypoxic-preconditioned C2C12 cells in 21% or 2% oxygen in vitro. Out data show that the long-term hypoxic culture condition does not affect the proliferation of C2C12 cells but leads to rounder cells and reduced myotube formation when compared with myoblasts exposed to normoxia. However, when normoxic- and hypoxic-preconditioned myoblasts were differentiated together, the resultant myotubes were significantly larger than the control myotubes. Whole transcriptome sequencing analysis revealed several novel candidate genes that are differentially regulated during the differentiation under normoxia and hypoxia in mixed culture conditions and may thus be involved in the increase in myotube size. Taken together, oxygen-dependent adaption and interaction of myoblasts may represent a novel approach for the development of innovative therapeutic targets.
Identifiants
pubmed: 35326510
pii: cells11061059
doi: 10.3390/cells11061059
pmc: PMC8947054
pii:
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Mol Sci. 2020 Sep 25;21(19):
pubmed: 32992783
PLoS One. 2018 Sep 21;13(9):e0204283
pubmed: 30240405
Am J Surg. 1988 Aug;156(2):83-6
pubmed: 3400818
J Biol Chem. 1999 Jul 9;274(28):19807-13
pubmed: 10391924
Colorectal Dis. 2015 Sep;17(9):794-801
pubmed: 25773013
Stem Cell Res Ther. 2018 Sep 13;9(1):233
pubmed: 30213273
Mol Biol Cell. 1998 Nov;9(11):3119-31
pubmed: 9802901
Front Biosci. 2008 May 01;13:3786-92
pubmed: 18508473
Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):585-95
pubmed: 16099183
PLoS One. 2018 Dec 4;13(12):e0208474
pubmed: 30513114
J Appl Physiol (1985). 1998 Jun;84(6):1882-8
pubmed: 9609780
Dev Cell. 2009 Jan;16(1):35-46
pubmed: 19154717
Cancer Res. 2009 Nov 1;69(21):8499-506
pubmed: 19843849
Lab Invest. 2002 May;82(5):645-55
pubmed: 12004005
Gut. 2010 Jan;59(1):55-61
pubmed: 19875391
Nat Med. 2018 Sep;24(9):1360-1371
pubmed: 30061698
Muscle Nerve. 2004 Oct;30(4):497-500
pubmed: 15372441
PLoS One. 2014 Jun 25;9(6):e100594
pubmed: 24963862
Front Physiol. 2021 Feb 10;12:632886
pubmed: 33679444
Stem Cell Res Ther. 2017 Sep 29;8(1):215
pubmed: 28962638
J Biol Chem. 2004 Aug 27;279(35):36795-802
pubmed: 15194693
Am J Physiol Cell Physiol. 2011 Mar;300(3):C671-82
pubmed: 21191105
Cell Stem Cell. 2010 Aug 6;7(2):150-61
pubmed: 20682444
PLoS One. 2012;7(11):e49860
pubmed: 23166781
Cancer Sci. 2012 Sep;103(9):1631-9
pubmed: 22642751
Mol Med Rep. 2016 Mar;13(3):2885-91
pubmed: 26847210
Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1693-701
pubmed: 17634197
Mol Pharmacol. 2010 Oct;78(4):560-8
pubmed: 20826425
Mol Cell Biochem. 2017 Nov;435(1-2):47-58
pubmed: 28497372
J Cell Biol. 2002 Sep 2;158(5):953-65
pubmed: 12213839
Peptides. 2008 Nov;29(11):2013-23
pubmed: 18692535
Nat Med. 2004 Aug;10(8):789-99
pubmed: 15286780
Mol Biol Cell. 2007 May;18(5):1723-33
pubmed: 17332502
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Int J Mol Sci. 2020 Aug 04;21(15):
pubmed: 32759823
Gene. 2019 Jul 30;707:36-43
pubmed: 30930226
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24691-24700
pubmed: 32968017
Cancer Res. 2015 Mar 15;75(6):996-1008
pubmed: 25623234
J Biol Chem. 2004 Apr 16;279(16):16332-8
pubmed: 14754880
Cell Death Differ. 2008 Oct;15(10):1619-28
pubmed: 18566603
J Vet Med Sci. 2002 Apr;64(4):341-7
pubmed: 12014580
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5431-6
pubmed: 17374716
Cell Mol Life Sci. 2003 Jul;60(7):1376-93
pubmed: 12943226
J Clin Invest. 2010 Jan;120(1):223-41
pubmed: 20038795
PLoS One. 2017 Jul 21;12(7):e0181259
pubmed: 28732027
Biotechnol J. 2015 Apr;10(4):647-53
pubmed: 25650551
J Appl Physiol (1985). 2006 Oct;101(4):1215-21
pubmed: 16778000
Tissue Eng Part A. 2011 Jul;17(13-14):1747-58
pubmed: 21438665
Am J Orthop (Belle Mead NJ). 2012 Feb;41(2):E27-35
pubmed: 22482099
Nat Genet. 2009 Jun;41(6):753-61
pubmed: 19412179
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10844-8
pubmed: 7971972
Sports Med. 2004;34(4):221-9
pubmed: 15049714
J Physiol. 2008 Jun 15;586(12):2841-53
pubmed: 18420707
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2254-8
pubmed: 7892257
J Trauma Acute Care Surg. 2012 Jan;72(1):86-93
pubmed: 22310120
Am J Physiol Regul Integr Comp Physiol. 2009 Jan;296(1):R150-60
pubmed: 18945954
Nat Rev Genet. 2003 Jul;4(7):497-507
pubmed: 12838342
Int J Cardiol. 2010 Dec 3;145(3):601-2
pubmed: 20801532
Cancer Res. 2000 Dec 15;60(24):7075-83
pubmed: 11156414
Front Physiol. 2021 Jun 23;12:684899
pubmed: 34248671
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Int Rev Cell Mol Biol. 2012;298:229-317
pubmed: 22878108